Cargando…
A salpingeal carcinoma revealed after prophylactic salpingoophorectomy in an asymptomatic BRCA1 carrier with breast malignancy
INTRODUCTION: BRCA1 inherited mutation carriers face a lifetime risk of 72% to develop breast cancer and a percentage of 44% risk for ovarian cancer. PRESENTATION OF CASE: We present a case of a 35-year old Caucasian woman who, after the excision of a possible malignant finding on the right breast,...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6197605/ https://www.ncbi.nlm.nih.gov/pubmed/30340058 http://dx.doi.org/10.1016/j.ijscr.2018.10.014 |
_version_ | 1783364802501935104 |
---|---|
author | Giannos, Aris Stavrou, Sofoklis Douskos, Athanasios Drakakis, Peter Loutradis, Dimitrios |
author_facet | Giannos, Aris Stavrou, Sofoklis Douskos, Athanasios Drakakis, Peter Loutradis, Dimitrios |
author_sort | Giannos, Aris |
collection | PubMed |
description | INTRODUCTION: BRCA1 inherited mutation carriers face a lifetime risk of 72% to develop breast cancer and a percentage of 44% risk for ovarian cancer. PRESENTATION OF CASE: We present a case of a 35-year old Caucasian woman who, after the excision of a possible malignant finding on the right breast, was diagnosed with ductal breast carcinoma. The patient treatment included first chemotherapy and radiotherapy and then prophylactic bilateral mastectomy with plastic reconstructive surgery. At the age of 37, she underwent prophylactic laparoscopic bilateral salpingoophorectomy. The histological diagnosis of the surgical specimens was suggestive of a unilateral invasive high grade salpingeal cancer and the patient underwent an abdominal hysterectomy by laparotomy, omentectomy and bilateral pelvic lymphadenectomy. DISCUSSION: Women with known BRCA mutations are strongly recommended to consider a risk reducing prophylactic salpingoophorectomy (RRSO) from their early 40 s to gain maximum benefit in cancer risk reduction from the procedure. The prevalence of occult carcinomas in BRCA1 carriers is almost 1, 5% if the prophylactic bilateral salpingoophorectomy is performed before the age of 40, while this percentage may be increased to 3, 8% for women who undergo the surgery between 40 and 49 years. CONCLUSION: We present an interesting case, of an accidentally revealed salpingeal carcinoma via RRSO in an asymptomatic young premenopausal woman. |
format | Online Article Text |
id | pubmed-6197605 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-61976052018-10-24 A salpingeal carcinoma revealed after prophylactic salpingoophorectomy in an asymptomatic BRCA1 carrier with breast malignancy Giannos, Aris Stavrou, Sofoklis Douskos, Athanasios Drakakis, Peter Loutradis, Dimitrios Int J Surg Case Rep Article INTRODUCTION: BRCA1 inherited mutation carriers face a lifetime risk of 72% to develop breast cancer and a percentage of 44% risk for ovarian cancer. PRESENTATION OF CASE: We present a case of a 35-year old Caucasian woman who, after the excision of a possible malignant finding on the right breast, was diagnosed with ductal breast carcinoma. The patient treatment included first chemotherapy and radiotherapy and then prophylactic bilateral mastectomy with plastic reconstructive surgery. At the age of 37, she underwent prophylactic laparoscopic bilateral salpingoophorectomy. The histological diagnosis of the surgical specimens was suggestive of a unilateral invasive high grade salpingeal cancer and the patient underwent an abdominal hysterectomy by laparotomy, omentectomy and bilateral pelvic lymphadenectomy. DISCUSSION: Women with known BRCA mutations are strongly recommended to consider a risk reducing prophylactic salpingoophorectomy (RRSO) from their early 40 s to gain maximum benefit in cancer risk reduction from the procedure. The prevalence of occult carcinomas in BRCA1 carriers is almost 1, 5% if the prophylactic bilateral salpingoophorectomy is performed before the age of 40, while this percentage may be increased to 3, 8% for women who undergo the surgery between 40 and 49 years. CONCLUSION: We present an interesting case, of an accidentally revealed salpingeal carcinoma via RRSO in an asymptomatic young premenopausal woman. Elsevier 2018-10-12 /pmc/articles/PMC6197605/ /pubmed/30340058 http://dx.doi.org/10.1016/j.ijscr.2018.10.014 Text en © 2018 The Authors http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Giannos, Aris Stavrou, Sofoklis Douskos, Athanasios Drakakis, Peter Loutradis, Dimitrios A salpingeal carcinoma revealed after prophylactic salpingoophorectomy in an asymptomatic BRCA1 carrier with breast malignancy |
title | A salpingeal carcinoma revealed after prophylactic salpingoophorectomy in an asymptomatic BRCA1 carrier with breast malignancy |
title_full | A salpingeal carcinoma revealed after prophylactic salpingoophorectomy in an asymptomatic BRCA1 carrier with breast malignancy |
title_fullStr | A salpingeal carcinoma revealed after prophylactic salpingoophorectomy in an asymptomatic BRCA1 carrier with breast malignancy |
title_full_unstemmed | A salpingeal carcinoma revealed after prophylactic salpingoophorectomy in an asymptomatic BRCA1 carrier with breast malignancy |
title_short | A salpingeal carcinoma revealed after prophylactic salpingoophorectomy in an asymptomatic BRCA1 carrier with breast malignancy |
title_sort | salpingeal carcinoma revealed after prophylactic salpingoophorectomy in an asymptomatic brca1 carrier with breast malignancy |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6197605/ https://www.ncbi.nlm.nih.gov/pubmed/30340058 http://dx.doi.org/10.1016/j.ijscr.2018.10.014 |
work_keys_str_mv | AT giannosaris asalpingealcarcinomarevealedafterprophylacticsalpingoophorectomyinanasymptomaticbrca1carrierwithbreastmalignancy AT stavrousofoklis asalpingealcarcinomarevealedafterprophylacticsalpingoophorectomyinanasymptomaticbrca1carrierwithbreastmalignancy AT douskosathanasios asalpingealcarcinomarevealedafterprophylacticsalpingoophorectomyinanasymptomaticbrca1carrierwithbreastmalignancy AT drakakispeter asalpingealcarcinomarevealedafterprophylacticsalpingoophorectomyinanasymptomaticbrca1carrierwithbreastmalignancy AT loutradisdimitrios asalpingealcarcinomarevealedafterprophylacticsalpingoophorectomyinanasymptomaticbrca1carrierwithbreastmalignancy AT giannosaris salpingealcarcinomarevealedafterprophylacticsalpingoophorectomyinanasymptomaticbrca1carrierwithbreastmalignancy AT stavrousofoklis salpingealcarcinomarevealedafterprophylacticsalpingoophorectomyinanasymptomaticbrca1carrierwithbreastmalignancy AT douskosathanasios salpingealcarcinomarevealedafterprophylacticsalpingoophorectomyinanasymptomaticbrca1carrierwithbreastmalignancy AT drakakispeter salpingealcarcinomarevealedafterprophylacticsalpingoophorectomyinanasymptomaticbrca1carrierwithbreastmalignancy AT loutradisdimitrios salpingealcarcinomarevealedafterprophylacticsalpingoophorectomyinanasymptomaticbrca1carrierwithbreastmalignancy |